Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, Coronary Interventions and Diagnostics, and Cardiovascular Function and Risk Factors.
Fibrinolytic Therapy for Thromboembolic Diseases
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial
Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics
Coexistence and outcome of coronary artery disease in Takotsubo syndrome
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction
Diabetes, heart failure, and renal dysfunction: The vicious circles
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y <sub>12</sub> inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54
Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c
Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials
Vorapaxar in Patients With Peripheral Artery Disease
Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure With Preserved Ejection Fraction
Dynamic TIMI Risk Score for STEMI
Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends
A Tale of Coronary Artery Disease and Myocardial Infarction
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction